Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2018.582 | Pharmacological Treatment of Mitochondrial Dysfunction in Diabetic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2016.721 | Urinary Mitochondrial DNA Level as a Biomarker of Chronic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2015.228 | Relation Between Peritoneal Dialysis Effluent microRNA Level and Longitudinal Change in Peritoneal Transport Characteristics |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2017.648 | Extracellular Mitochondrial DNA Released by Peritoneal Mesothelial Cell as the Trigger of Macrophage Activation |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2016.483 | Cost-effectiveness analysis of screening of BK virus-associated nephropathy using urine cytology and serum quantitative polymerase chain reaction |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2015.250 | Genetic Determinants of Peritoneal Transport Characteristics and Cardiovascular Diseases for Peritoneal Dialysis Patients |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2014.482 | A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy | Prof. SZETO Cheuk Chun |
| 2017.368 | Urinary Sediment RNA Profile for the Prediction of Therapeutic Response in Lupus Nephritis |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2015.327 | The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients with High Dialysis Effluent Bacterial DNA Fragment Levels |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2014.564 | Urinary Podocyte mRNA as a Prognostic Marker of Diabetic Nephropathy | Prof. SZETO Cheuk Chun |
| 2016.480 | Urinary RNA Levels as Prognostic Indicators of Chronic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2014.352 | Long Non-Coding RNA (IncRNA) in the Urinary Sediment of Patients with Chronic Kidney Disease | Professor SZETO Cheuk Chun |
| 2017.420 | Urinary miRNA profile as the biomarker of IgA nephropathy |
Prof Szeto Cheuk Chun 司徒卓俊 |
| 2024.402 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Povetacicept in Adults with Immunoglobulin A Nephropathy (RAINIER) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.315 | Discontinuation of sodium-glucose cotransporter-2 inhibitors in advanced chronic kidney disease |
Professor Szeto Cheuk Chun 司徒卓俊 |
| 2024.178 | The Efficacy and Safety of Intermittent Sodium Zirconium Cyclosilicate Therapy for the Prevention of Hyperkalemia in Chronic Kidney Disease |
Professor Szeto Cheuk Chun Szeto Cheuk Chun |
| 2024.321 | Defining the optimal frequency of dialysis adequacy test for peritoneal dialysis patients |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.381 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2022.125 | A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy |
Prof SZETO Cheuk Chun 司徒卓俊 |
| 2021.307 | A Phase IIa, Open-Label, 2-Arm Multicenter Clinical Trial to Evaluate the Efficacy, Safety and PK/PD of the Human Anti-CD38 Antibody MOR202 in Anti-PLA2R Antibody Positive Membranous Nephropathy (NewPLACE) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2010.410 | Week 24 response and long-term outcomes of lamivudine in patients with chronic hepatitis B - A prospective cohort study | Dr. SZE YUEN CHUN |
| 2011.256 | Prospective study on lcinical predictive value of hepatitis B surface antigen for sustained virologic response to pegylated interferon in patients infected with chronic hepatitis B | Dr. SZE YUEN CHUN |
| 2024.097 | The impact of sign-phonological awareness training on language and literacy development in deaf and hearing bimodal bilingual children | Prof. SZE Yim Binh Felix |
| 2015.561 | Prognostic factors of paediatrics traumatic brain injuries. A review of case series with neurosurgical intervention in a tertiary trauma center from 2003 to 2013. | Dr. SZE Wang Pui |
| 2022.528 | Retrospective review of COVID-19 Older Patients in the community treatment facility at AsiaWorld-Expo - Geriatric Syndromes, Discharge Planning and Outcomes |
Ms. SZE Savina Yee Man 史綺雯 |
| 2022.073 | Diagnostic accuracy of using capnography in verification of nasogastric tube placement in hospital settings | Ms. SZE Savina Yee Man |
| 2021.144 | Evaluation of Lift and Place Test with Pain and Disability Scales among Healthy Adults with Non-specific Low Back Pain | Mr. SUTANTO Dhananjaya |
| 2022.176 | Change in chronic low back pain participant trunk and lower limb kinematics after structural exercise program | Mr. SUTANTO Dhananjaya |
| 2008.028 | Genetic Determination of Susceptibility to Kawasaki Disease: A Study of Genomic DNA Recovered from Saliva Samples | Professor Sung Yn Tz, Rita |
| 2024.280 | Improving Accuracy of Genomic Variation Calling in the Hong Kong Population | Prof. Sung Wing Kin |
| 2010.362 | Effectiveness of fall alarm pad in fall prevention for the at risk group of the Chinese elderly in acute hospital of Hong Kong | MR. SUNG Man Ho, Charles |
| 2009.404 | A pharmacokinetic/pharmacodynamic evaluation of ABF656 in subjects with chronic hepatitis B, eAg+, infection | Prof. SUNG Joseph JY |
| 2008.404 | Comparing Acceptance and Yield of Colonoscopy Versus Fecal Immunochemical Test (FIT) in the Detection of Advanced Colonic Neoplasm in Asia (CFA Study) | Prof. SUNG Joseph JY |
| 2010.165 | Functional Significance and Gene Modulation of a Novel Tumor Suppressor T-box 5 in Colon Cancer | Professor SUNG JOSEPH JY |
| 2008.143 | Functional Significance and Potential Clinical Application of a Novel Putative Tumor Suppressor (zinc finger protein 331) in Gastric Cancer | Dr SUNG Joseph JY |
| 2009.106 | A Follow-up Study to Evaluate the Long-term Post Treatment Effects of Peginterferon Alfa-2a (PEG-IFN) in Patients with HBeAg Positive Chronic Hepatitis B from the Original Study WV19432 (NEPTUNE) | Prof Sung Joseph Jao-Yiu |
| 2011.503 | Validation of Asia-Pacific Colorectal Screening Score (APCS score) | Prof. SUNG Joseph Jao Yiu |
| 2017.055 | A retrospective analysis - would Baylor Bleeding Score be able to identify the patients who are at high risk of rebleeding? | Prof. SUNG Joseph Jao Yiu |
| 2018.535 | Non-warfarin Oral AntiCoagulant resumption after Gastrointestinal bleeding in Atrial fibrillation Patients (NOAC-GAP) - a randomised controlled study |
Prof. SUNG Joseph Jao Yiu 沈祖堯 |
| 2019.504 | Treatment of DM/Pre-DM in obese patients and its effects on microbiome, colonic adenoma and NAFLD | Prof. SUNG Joseph Jao Yiu |
| 2020.219 | The diagnostic performance of fecal immunochemical test for detecting colorectal neoplasm in 40 to 49 year-old adults: retrospective review of medical records | Prof. SUNG Joseph Jao Yiu |
| 2019.394 | Inflammatory bowel disease and risk prediction for acute severe colitis |
Prof. SUNG Joseph Jao Yiu 沈祖堯 |
| 2018.234 | A multi-centered study: New technologies and plans for colorectal cancer screening |
Prof. SUNG Joseph Jao Yiu 沈祖堯 |
| 2012.139 | Investigating the Intestinal Microbiota in Colorectal Neoplasia and Obesity (COM Study) | Prof SUNG Joseph |
| 2011.297 | The Use of Office-based M2-PK Stool Test in the Diagnosis of Colorectal Cancer in Asians | Prof. Sung Joseph |
| 2010.582 | Evaluationg the performance of Given dignostic system in detection of bleeding events in the small bowel | Prof. Sung Joseph |
| 2011.150 | Clinical Evaluation of Hemospray: Hemostasis of Active GI Luminal Tract Bleeding (HALT) | Prof. Sung Joseph |
| 2012.371 | Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma: A Multicenter, Randomized, Controlled Trial | Prof. Sung Joseph |
| 2008.514 | A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients with Moderate to Severe Ulcerative Colitis | Prof Sung Joseph |
| 2008.508 | A Phase 3, Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab MLN0002 in Patients with Ulcerative Colitis and Crohn | Prof Sung Joseph |
Page 63 of 254.